According to a new market research report published by Global Market
Estimates, the Global Companion Animal Pharmaceuticals Market is projected to
grow from USD 13.2 billion in 2022 to USD 19.5 billion by 2027 at a CAGR value
of 7.8% from 2022 to 2027.
Zoetis Inc., Merck &
Co., Inc., Boehringer Ingelheim GmbH, Elanco Animal Health Incorporated, Ceva
Santé Animale, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals plc, Chanelle
Pharma, Kyoritsu Seiyaku, among others are the key players in the companion
animal pharmaceuticals market.
The rapidly increasing number of pet ownership, accelerated commitment of
owners to pay for optimal healthcare, expanded pet life expectancies, and the
introduction of age-related illness targets such as rheumatoid arthritis,
cancers, and obesity are all contributing to an explosive growth trend in the
companion animal health sector during the forecast period.
Browse 151 Market Data
Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Visually
Impaired Assistive Apps Market -
Forecast to 2027” https://www.globalmarketestimates.com/market-report/companion-animal-pharmaceuticals-market-3773
Indication Outlook (Revenue, USD Billion, 2022 - 2027)
·
Infectious Diseases
·
Dermatologic Diseases
·
Pain
·
Orthopedic Diseases
·
Behavioral Diseases
·
Other Indications
Animal Type Outlook (Revenue, USD Billion,
2022 - 2027)
·
Dogs
·
Cats
·
Horses
·
Other Companion Animals
Distribution Channel Outlook (Revenue,
USD Billion, 2022 - 2027)
·
Veterinary Hospitals
·
Veterinary Clinics
·
Retail Pharmacies
Regional Outlook (Revenue, USD Billion, 2022-2027)
North America
- The
U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest
of Europe
Asia Pacific
- China
- India
- Japan
- South
Korea
- Australia
- Rest
of APAC
Central & South America
- Brazil
- Argentina
- Rest
of CSA
Middle East & Africa
- Saudi
Arabia
- UAE
- Rest
of MEA
Contact:
Yash Jain
Email
address: yash.jain@globalmarketestimates.com
Phone
Number: +16026667238